Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (271-280 of 528) with videos related to

Pageof 53
Sort By:
The American Journal of Pathology|April 25, 2009
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytesHong Yu, Ronan McDaid, John Lee, et al.
Clinical Epigenetics|December 21, 2023
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wideProdromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2021
HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal StudyDavid J Margolis, Nandita Mitra, Brian S Kim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 16, 2014
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancerKara N Maxwell, Bradley Wubbenhorst, Kurt D'Andrea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodSurya P Rednam, Ayelet Erez, Harriet Druker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cellsClemens Krepler, Srinivas K Chunduru, Molly B Halloran, et al.
Clinical Breast Cancer|June 27, 2007
Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United StatesJulia Tchou, M Renee Ward, Patricia Volpe, et al.
Molecular Cancer Therapeutics|September 16, 2008
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomasKeiran S M Smalley, Mercedes Lioni, Maurizia Dalla Palma, et al.
Breast Cancer Research and Treatment|April 5, 2020
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndromeAnh N Le, Joanna Harton, Heena Desai, et al.
Genetics in Medicine Open|February 3, 2025
Pilot implementation study of a default genetic referral process for patients with early-onset colorectal cancerKelsey S Lau-Min, Shavon Rochester, Megan Grabill, et al.
Pageof 53

Showing results (271-280 of 528) with videos related to

Sort By:
Pageof 53
The American Journal of Pathology|April 25, 2009
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytesHong Yu, Ronan McDaid, John Lee, et al.
Clinical Epigenetics|December 21, 2023
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wideProdromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2021
HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal StudyDavid J Margolis, Nandita Mitra, Brian S Kim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 16, 2014
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancerKara N Maxwell, Bradley Wubbenhorst, Kurt D'Andrea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodSurya P Rednam, Ayelet Erez, Harriet Druker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cellsClemens Krepler, Srinivas K Chunduru, Molly B Halloran, et al.
Clinical Breast Cancer|June 27, 2007
Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United StatesJulia Tchou, M Renee Ward, Patricia Volpe, et al.
Molecular Cancer Therapeutics|September 16, 2008
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomasKeiran S M Smalley, Mercedes Lioni, Maurizia Dalla Palma, et al.
Breast Cancer Research and Treatment|April 5, 2020
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndromeAnh N Le, Joanna Harton, Heena Desai, et al.
Genetics in Medicine Open|February 3, 2025
Pilot implementation study of a default genetic referral process for patients with early-onset colorectal cancerKelsey S Lau-Min, Shavon Rochester, Megan Grabill, et al.
Pageof 53